Videregen Company

Organs Grown on Scaffolds
Technology:
Regenerative Medicine
Industry:
Risk Mitigation
Headquarters:
UK
Founded Date:
2011
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
4
Total Funding:
$4.27
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series A
Register and Claim Ownership